MOLECULAR PHARMACOLOGY (USA) LTD. Amortization
MOLECULAR PHARMACOLOGY (USA) LTD. reported Amortization of $6.93 thousand for the 123-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2014-11-13
- MOLECULAR PHARMACOLOGY (USA) LTD. amortization for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- MOLECULAR PHARMACOLOGY (USA) LTD. amortization for the quarter ending 2013-09-30 was $11.00.
- MOLECULAR PHARMACOLOGY (USA) LTD. amortization for fiscal 2014 was $43.00, a 78.06% decline from fiscal 2013.
- MOLECULAR PHARMACOLOGY (USA) LTD. amortization for fiscal 2013 was $196.00, a 56.35% decline from fiscal 2012.
- MOLECULAR PHARMACOLOGY (USA) LTD. amortization for fiscal 2012 was $449.00.
| Period end | Amortization 3 month | Amortization 12 month | Amortization 120 month | Amortization 123 month |
|---|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-Q 123 month − 10-K 120 month · filed 2014-11-13 | $6.93K 10-Q · filed 2014-11-13 | ||
| 2014-06-30 | $43.00 10-K · filed 2014-09-08 | $6.93K 10-K · filed 2014-09-08 | ||
| 2013-09-30 | $11.00 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $196.00 10-K · filed 2014-09-08 | |||
| 2012-06-30 | $449.00 10-K · filed 2014-09-08 |